Neutralizing antibody titer after recommended early vaccination against Japanese encephalitis
Objective Following the case of a 10-month-old with Japanese encephalitis in Chiba in 2015, the Chiba Pediatric Association and Chiba Medical Association recommended that children receive the Japanese encephalitis vaccine at six months of age. In this study, we investigated early vaccinations and st...
Saved in:
Published in | Nihon Koshu Eisei Zasshi(JAPANESE JOURNAL OF PUBLIC HEALTH) Vol. 70; no. 4; pp. 22-001 - 251 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | Japanese |
Published |
Japan
Japanese Society of Public Health
25.04.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective Following the case of a 10-month-old with Japanese encephalitis in Chiba in 2015, the Chiba Pediatric Association and Chiba Medical Association recommended that children receive the Japanese encephalitis vaccine at six months of age. In this study, we investigated early vaccinations and standard vaccinations of children in a patient outbreak area. Additionally, we examined changes in the timing of vaccination initiation and the acquisition and maintenance of protective immunity before and after the early vaccination recommendation.Methods With the cooperation of the medical institution designated for Type II Infectious Diseases, which treated affected children in 2015, the history and timing of vaccinations for children who visited the hospital between October 2018 and March 2020 were investigated, and serum samples were collected. The data obtained in this study and the Ministry of Health, Labour and Welfare's Community Health Service Report were used to investigate the timing of vaccinations. Neutralizing antibody titers in serum were quantified with the focus measurement method and examined with respect to the number of vaccinations, doses, and number of days since vaccination.Results A total of 154 samples were obtained, with 89 from the vaccinated group and 65 from the unvaccinated group. There was no difference in the percentage of children based on the age of first vaccination between Japan, Chiba Prefecture, and the study subjects until FY2015, but from FY2016 onward, the percentage of children vaccinated early was higher among the study subjects, as well as for children from Chiba Prefecture and Japan, in that order. The antibody possession rate by vaccination frequency was 9.2% for the unimmunized, 87.5% for those vaccinated once, 95.1% for those vaccinated twice, and 100% for those vaccinated three times. In the group vaccinated twice, antibody titers of children who received half the vaccine dose were significantly lower than those of children who received the normal dose.Conclusion In the districts targeted in this study, significantly more children under three years of age were vaccinated before the early vaccination recommendation, suggesting the effectiveness of that recommendation. In addition, the high rate of antibody positivity among unvaccinated children suggests that it is important to promote early vaccination in areas at high risk for Japanese encephalitis. In this study, there was no evidence of attenuation of antibody titers over time after early immunization, but the possibility remains that the children who completed early immunization received a booster due to pathogen exposure and maintained antibody titers, given that Japanese encephalitis was endemic in the target area. |
---|---|
AbstractList | Objective Following the case of a 10-month-old with Japanese encephalitis in Chiba in 2015, the Chiba Pediatric Association and Chiba Medical Association recommended that children receive the Japanese encephalitis vaccine at six months of age. In this study, we investigated early vaccinations and standard vaccinations of children in a patient outbreak area. Additionally, we examined changes in the timing of vaccination initiation and the acquisition and maintenance of protective immunity before and after the early vaccination recommendation.Methods With the cooperation of the medical institution designated for Type II Infectious Diseases, which treated affected children in 2015, the history and timing of vaccinations for children who visited the hospital between October 2018 and March 2020 were investigated, and serum samples were collected. The data obtained in this study and the Ministry of Health, Labour and Welfare's Community Health Service Report were used to investigate the timing of vaccinations. Neutralizing antibody titers in serum were quantified with the focus measurement method and examined with respect to the number of vaccinations, doses, and number of days since vaccination.Results A total of 154 samples were obtained, with 89 from the vaccinated group and 65 from the unvaccinated group. There was no difference in the percentage of children based on the age of first vaccination between Japan, Chiba Prefecture, and the study subjects until FY2015, but from FY2016 onward, the percentage of children vaccinated early was higher among the study subjects, as well as for children from Chiba Prefecture and Japan, in that order. The antibody possession rate by vaccination frequency was 9.2% for the unimmunized, 87.5% for those vaccinated once, 95.1% for those vaccinated twice, and 100% for those vaccinated three times. In the group vaccinated twice, antibody titers of children who received half the vaccine dose were significantly lower than those of children who received the normal dose.Conclusion In the districts targeted in this study, significantly more children under three years of age were vaccinated before the early vaccination recommendation, suggesting the effectiveness of that recommendation. In addition, the high rate of antibody positivity among unvaccinated children suggests that it is important to promote early vaccination in areas at high risk for Japanese encephalitis. In this study, there was no evidence of attenuation of antibody titers over time after early immunization, but the possibility remains that the children who completed early immunization received a booster due to pathogen exposure and maintained antibody titers, given that Japanese encephalitis was endemic in the target area. |
Author | KITAZAWA, Katsuhiko OITATE, Noriko OGAWA, Tomoko SATO, Shinichi |
Author_xml | – sequence: 1 fullname: OITATE, Noriko organization: Chiba Prefectural Institute of Public Health – sequence: 2 fullname: KITAZAWA, Katsuhiko organization: Department of Pediatrics, Asahi General Hospital, Chiba – sequence: 3 fullname: OGAWA, Tomoko organization: Chiba Prefectural Institute of Public Health – sequence: 4 fullname: SATO, Shinichi organization: Chiba Prefectural Institute of Public Health |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36567131$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kbtPwzAQxi1URMtjYkcZWVL8SOx0RIinECwwIusSX1tXiRNsp1L56zGicMN9N_zu0-m7YzJxvUNCzhmdM8aFvNoM6znnOaXsgMw4q1ReLSo5ITNaFjJnSsopOQthQ1NJymQhjshUyFIqJtiMfLzgGD209su6VQYu2ro3uyzaiD6D5U_32PRdh86gyRB8u8u20DTWQbS9y2AF1oWYPcEADgNm6Boc1skx2nBKDpfQBjzb6wl5v7t9u3nIn1_vH2-un_MN44zlxnCBHJjiipskjaJYV6JEgwUTYFBCyWtVSAVFbYDWii7lslQi0QulhDghl7--g-8_RwxRdzY02LbppH4Mmqsy2RWqogm92KNj3aHRg7cd-J3-iyQBD7_AJkRY4T8APtqmRZ0C12C2aV3Tv4FznR7wjzRr8Bqd-AY0moHi |
ContentType | Journal Article |
Copyright | 2022 Japanese Society of Public Health |
Copyright_xml | – notice: 2022 Japanese Society of Public Health |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.11236/jph.22-001 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2187-8986 |
EndPage | 251 |
ExternalDocumentID | 36567131 article_jph_advpub_0_advpub_22_001_article_char_en |
Genre | English Abstract Journal Article |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS JSF KQ8 OK1 RJT CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-j1211-dd23e2a17272da17c70eb835ede413ade6a52b7467a4bda0b70f6f5732da97733 |
ISSN | 0546-1766 |
IngestDate | Fri Apr 12 02:58:22 EDT 2024 Thu May 23 23:32:50 EDT 2024 Sun Jul 28 05:52:41 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 4 |
Keywords | early vaccination neutralizing antibody titer Japanese encephalitis vaccination |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j1211-dd23e2a17272da17c70eb835ede413ade6a52b7467a4bda0b70f6f5732da97733 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/jph/advpub/0/advpub_22-001/_article/-char/en |
PMID | 36567131 |
PQID | 2758354780 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2758354780 pubmed_primary_36567131 jstage_primary_article_jph_advpub_0_advpub_22_001_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2023-Apr-25 |
PublicationDateYYYYMMDD | 2023-04-25 |
PublicationDate_xml | – month: 04 year: 2023 text: 2023-Apr-25 day: 25 |
PublicationDecade | 2020 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Nihon Koshu Eisei Zasshi(JAPANESE JOURNAL OF PUBLIC HEALTH) |
PublicationTitleAlternate | Jpn J Public Health |
PublicationYear | 2023 |
Publisher | Japanese Society of Public Health |
Publisher_xml | – name: Japanese Society of Public Health |
References | 2) Arahata Y, Fujii K, Nishimura T, et al. Longitudinal magnetic resonance imaging changes in Japanese encephalitis. Brain Dev 2019; 41: 731-734. 18) 太田茉里,田﨑穂波,追立のり子,他.炭酸ガスライトトラップを用いて捕集した蚊の日本脳炎ウイルス保有状況調査.千葉県衛研年報 2020; 69: 68-70. 11) 厚生労働省健康局結核感染症課 国立感染症研究所感染症流行予測調査事業委員会.感染症流行予測調査事業検査術式 令和元年度改訂版 2019; 34-48. 14) 千葉県.年齢別・町丁字別人口平成30年度 第2表年齢(5歳階級,各歳)別男女別人口.https://www.pref.chiba.lg.jp/toukei/toukeidata/nenreibetsu/h30/h30-nennrei.html(2022年3月13日アクセス可能) 10) Okuno Y, Fukunaga T, Tadano M, et al. Rapid focus reduction neutralization test of Japanese encephalitis virus in microtiter system. Arch Virol 1985; 86: 129-135. 16) 千葉県衛生研究所.2019年度(令和元年度)千葉県衛生研究所年報千葉県における蚊の生息実態調査.千葉県衛研年報 2019. 19) 沢辺京子.日本脳炎ウイルスの国内越冬と海外飛来.化学療法の領域 2014; 30: 39-49. 7) Miyazaki C, Okada K, Ozaki T, et al. Phase III Clinical trials comparing the immunogenicity and safety of the Vero cell-derived Japanese encephalitis vaccine Encevac with those of mouse brain-derived vaccine by using the Beijing-1 strain. Clin Vaccine Immunol 2014; 21: 188-195. 9) Deng X, Yan J, He H, et al. Serological and molecular epidemiology of Japanese Encephalitis in Zhejiang, China, 2015-2018. PLoS Negl Trop Dis 2020; 14: e0008574. 8) Okada K, Iwasa T, Namazue J, et al. Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children. Vaccine 2012; 30: 5967-5972. 6) 国立感染症研究所.令和元年度(2019年度)感染症流行予測調査報告書 第4日本脳炎.https://www.niid.go.jp/niid/images/epi/yosoku/AnnReport/2019/04.pdf(2021年11月27日アクセス可能) 13) 厚生労働省地域保健・健康増進事業報告.https://www.e-stat.go.jp/stat-search/files?page=1&toukei=00450025&tstat=000001030884&cycle=8(2022年3月13日アクセス可能) 1) 厚生労働省.定期接種実施要領 第2各論3日本脳炎の定期接種.https://www.mhlw.go.jp/bunya/kenkou/teiki-yobou/10.html(2021年11月27日アクセス可能) 3) 公益社団法人 日本小児科学会.日本脳炎罹患リスクの高いものに対する生後6か月からの日本脳炎ワクチンの推奨について.2016年2月.https://www.jpeds.or.jp/modules/news/index.php?content_id=197(2021年11月27日アクセス可能) 12) Oya A. Japanese encephalitis vaccine. Acta Paediatr Jpn 1988; 30: 175-184. 15) 追立のり子,平良雅克,秋田真美子,他.千葉県での日本脳炎ウイルスの動態について.IASR 2017; 38: 154-155. 4) 千葉県医師会.千医第354号 平成28年3月22日 生後6か月からの日本脳炎ワクチンの推奨について(要望).https://www.chiba.med.or.jp/members/fileview.php?filename=11_0_20160325123038.pdf&dir1=public&dir2=201603(2021年12月15日アクセス可能) 5) 千葉県小児科医会.日本脳炎推奨ポスター 2016年8月.www.chibasyouni.com/wordpress/wp-content/uploads/2016/08/nihonnoen.pdf(2021年11月27日アクセス可能) 20) 東北メディカル・メガバンク機構.新型コロナウイルスワクチンによる抗体産生.https://www.megabank.tohoku.ac.jp/cms/wp-content/uploads/2022/02/ID47916_pressrelease03.pdf(2022年3月26日アクセス可能) 17) Baig S, Fox K, Jee Y, et al. Japanese encephalitis surveillance and immunization—Asia and the Western Pacific, 2012. MMWR Morb Mortal Wkly Rep 2013; 62: 658-662. |
References_xml | |
SSID | ssj0000601643 ssib005879738 ssib006571138 ssib020472901 ssib024195463 ssib023167666 ssib000959828 |
Score | 2.393693 |
Snippet | Objective Following the case of a 10-month-old with Japanese encephalitis in Chiba in 2015, the Chiba Pediatric Association and Chiba Medical Association... |
SourceID | proquest pubmed jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 22-001 |
SubjectTerms | Antibodies, Neutralizing Antibodies, Viral Child Child, Preschool early vaccination Encephalitis Virus, Japanese Encephalitis, Japanese - prevention & control Humans Immunization, Secondary Infant Japanese encephalitis neutralizing antibody titer Vaccination |
Title | Neutralizing antibody titer after recommended early vaccination against Japanese encephalitis |
URI | https://www.jstage.jst.go.jp/article/jph/advpub/0/advpub_22-001/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/36567131 https://search.proquest.com/docview/2758354780 |
Volume | 70 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Nihon Koshu Eisei Zasshi(JAPANESE JOURNAL OF PUBLIC HEALTH), 2022, pp.22-001 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgvPCCQNwKAxmJPUUZqZ1bH8vYNI3RCa2V-oIiO3GadOpS0XST-us5x3Zac5MGL821TXr85fg7ds53CHkvmCxFnnMfeu_CD-Mw9WVQch-ioRR6pyQvJSYKfxnFp5PwbBpNf8kuaeVhvvljXsn_tCrsg3bFLNl_aNntj8IOWIf2hU9oYfi8UxuP1FoPVGxMpmFby6YANolZxbb4N8a7i4Ue5vaU1jK-AZvVZgjQEzNRAz30zqDHxEqUHj7mywqpeb1yaeuoruD0q4Oj6CD9tKpwOfzoqXqlam8D9Luqt4O1tdbCMDNC9VWzm-NvxUbc2gS0drWunIMXM3tk3Cya3e5LoWs8eZcVZm_aa9gRCsZxssVkM1tHFoWxFqJ0va4pF2LRFbou1Mg22d6YGTna3x0906Vo5svqEKLpwA6I_CSnPbrITibn59n4eDq-Tx4w8EToAj9_dfjnAPULHT2zNBm4enRxlPT7u22G0ppdAS_cRhkBJ_4DNjTYlhcwVAAVzPRbDp0NbI4o3v-H3d0D_5lDNDBTfw90NOEZPyaPbKRChwZ2T8i9uXhKvrmQox3kqIYc1ZCjDuSohhx1IEct5GgHOepC7hmZnByPj059W6HDn6M0oF8UjCsmkASzAhZ5EigJnF4VCsiRKFQsIiaxoo0IZSECmQRlXEYJh7Mh8OD8Odm7bq7VS0LLMohUWWIhtTCUgzwVPIUOB5YSOX_cI0NjoWxpZFgy-9hlYMVMFDdgqyzoVhjDlzW3p2AGIziMHnnXGTcDL4pTY_BXm_UqYxA2c5S2C3rkhbH69jocQp6kz_uv7vDt1-Th7gnYJ3vt97V6A6y1lW818n4AKC6VyA |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neutralizing+antibody+titer+after+recommended+early+vaccination+against+Japanese+encephalitis&rft.jtitle=Nihon+k%C5%8Dsh%C5%AB+eisei+zasshi&rft.au=Oitate%2C+Noriko&rft.au=Kitazawa%2C+Katsuhiko&rft.au=Ogawa%2C+Tomoko&rft.au=Sato%2C+Shinichi&rft.date=2023-04-25&rft.issn=0546-1766&rft.volume=70&rft.issue=4&rft.spage=243&rft.epage=251&rft_id=info:doi/10.11236%2Fjph.22-001&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0546-1766&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0546-1766&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0546-1766&client=summon |